[Treatments in the early stage of Parkinson disease].
Rascol
O
O
Laboratoire de pharmacologie clinique, Centre d'Investigation clinique, INSERM U825, pôle neurosciences, Centre hospitalier universitaire, Toulouse. rascol@cict.fr
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D018696:Neuroprotective Agents